COVID-19
Conditions
Interventions
The estimated sample size is 50 participants. Participants will undergo an initial assessment for eligibility through prior telephone contact - teleservice. Participants selected for the study must ap
- Control (physio+sham) determined G2. (25 participantes)
The evaluation will be carried out by a physiotherapist specialized in respiratory physiotherapy (examiner 1) with at least 2 years of experie
E02.190.599
Sponsors
Ana Paula Cochar
Escola de Osteopatia de Madrid - Brasil Ltda. (EOM - Brasil)
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Will be selected for this study, individuals between 18 and 60 years, both sexes, who had a positive diagnosis for COVID-19, confirmed by the RT-PCR test or who were diagnosed using clinical criteria associated with radiological image, computed tomography, D-dimer , presenting a picture compatible with COVID-19, hemodynamic stability and who presented a decrease in oxygen saturation. In addition, patients who did not progress to mechanical ventilatory support and who, after the active viral period, evolved with sequelae caused by the disease will be considered.
Exclusion criteria
Exclusion criteria: Participants will be excluded from the study if they present lowered level of consciousness or who are unable to obey simple commands, acute decline in neurological status; hypotension (MAP less 60 mmHg) or hypertension (MAP up to 120 mmHg); tetany; continuous renal replacement therapy; Body Mass Index - BMI up to 30 kg/m2; previous thoracic surgery; chest instability; presence of chest tube; with complications from other serious underlying diseases, such as decompensated diabetes, obstructive and restrictive pulmonary disease, coronary heart disease, stroke with sequelae, fractures with sequelae, cancer, osteoporosis, immunodeficiency, fever, use of illicit drugs, congenital malformations, deformities, rejection of the treatment and any clinical alteration that makes the handling and execution of the technique unfeasible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The hypothesis of the present study is that patients with sequelae after COVID-19 allocated in the experimental group (physio + BMT) show an acute improvement in lung function (eg, increase in maximal expiratory and inspiratory pressures and maximal expiratory flow) and in function cardiovascular (eg, decreased heart rate and 2% to 3% increase in oxygen saturation) after the treatment period when compared to the control group (physio+sham). | — |
Secondary
| Measure | Time frame |
|---|---|
| The hypothesis of the present study is that patients with sequelae after COVID-19 allocated in the experimental group (physio + BMT) show an acute improvement in lung function (eg, increase in maximal expiratory and inspiratory pressures and maximal expiratory flow) and in function cardiovascular (eg, decreased heart rate and 2% to 3% increase in oxygen saturation) after the treatment period when compared to the control group (physio+sham). | — |
Countries
Brazil
Contacts
Public ContactAna Cochar
Escola de Osteopatia de Madrid - Brasil Ltda. (EOM - Brasil)
Outcome results
None listed